insomnia
Conditions
Interventions
experimental group:The experimental group was treated with Mongolian medicine Sugemule-4
control group:The control group was treated with estazolam
Sponsors
The Fourth People's Hospital of Ordos City
Eligibility
Sex/Gender
All
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients clinically diagnosed with insomnia (evaluated by the PSQI scale), Asens scale (AIS), abnormal auditory evoked potential tests, abnormal sleep monitoring tests, and patients with clinical diagnostic elements of insomnia) 2. Clear consciousness and ability to understand language 3. Age over 18 years old and able to cooperate with treatment 4. Meets the diagnostic criteria for insomnia in CCMD-2-R.
Exclusion criteria
Exclusion criteria: 1. Individuals with a history of Mongolian medicine allergy. 2. Unclear and unable to cooperate with treatment 3. Patients with abnormal liver function and organic lesions in the middle stage of insomnia due to long-term insomnia 4. Breastfeeding, pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Athens Insomnia Scale;Pittsburgh sleep quality index;Near infrared brain functional imaging;Auditory evoked test;sleep monitoring; | — |
Countries
China
Contacts
Public ContactSun Lidong
The Fourth People's Hospital of Ordos City
Outcome results
None listed